Twist Bioscience (TWST) Cash from Operations (2017 - 2026)

Twist Bioscience has reported Cash from Operations over the past 10 years, most recently at 17559000.0 for Q1 2026.

  • Quarterly Cash from Operations fell 35.21% to 17559000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 55587000.0 through Mar 2026, up 0.94% year-over-year, with the annual reading at 47628000.0 for FY2025, 25.69% up from the prior year.
  • Cash from Operations was 17559000.0 for Q1 2026 at Twist Bioscience, up from 24814000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 1267000.0 in Q3 2022 and troughed at 54070000.0 in Q4 2022.
  • The 5-year median for Cash from Operations is 20704000.0 (2023), against an average of 22017705.88.
  • Year-over-year, Cash from Operations skyrocketed 96.36% in 2022 and then tumbled 1534.1% in 2023.
  • A 5-year view of Cash from Operations shows it stood at 54070000.0 in 2022, then surged by 57.51% to 22973000.0 in 2023, then rose by 6.73% to 21428000.0 in 2024, then decreased by 15.8% to 24814000.0 in 2025, then rose by 29.24% to 17559000.0 in 2026.
  • Per Business Quant, the three most recent readings for TWST's Cash from Operations are 17559000.0 (Q1 2026), 24814000.0 (Q4 2025), and 11814000.0 (Q3 2025).